Category: Antisense & RNAi Technology
Global Antisense & RNAi Technology
-
Biologics Market Report by Source (Microbial, Mammalian, and Others), Product (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi and Molecular Therapy, and Others), Disease (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, and Others), Manufacturing (Outsourced, In-House), and Region 2024-2032
... and Region 2024-2032 The global biologics market size reached US$ 349.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 699.5 Billion by 2032, exhibiting a growth rate (CAGR) of 7.8% ... Read More
-
Antisense and RNAi Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Technology (Antisense RNA and RNA Interference); By Route of Administration; By Application; By Region; Segment Forecast, 2024 - 2032
... RNAi therapeutics market size is expected to reach USD 18.43 billion by 2032, according to a new study by Polaris Market Research. The report “Antisense and RNAi Therapeutics Market Share, Size, Trends, Industry Analysis Report, ... Read More
-
Global RNAi Technologies Market Growth (Status and Outlook) 2024-2030
... downstream market, the RNAi Technologies is forecast to a readjusted size of US$ 414.1 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global ... Read More
-
Antisense & RNAi Therapeutics Global Market Report 2024
... Disorders; Infectious Diseases Covering: Biogen Inc.; Ionis Pharmaceuticals Inc.; Alnylam Pharmaceuticals Inc.; Arrowhead Pharmaceuticals Inc.; Moderna Inc. Antisense & RNAi Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Global Antisense and RNAi therapeutics Market Size study & Forecast, by Technology (RNA Interference, Antisense RNA) by Application (Genetic Disease, Cancer, Infectious Disease, Neurodegenerative Disorders, Cardiometabolic & Renal Disorders, Ocular Disorders, Respiratory Disorders, Skin Disorders), by Route of Administration (Intravenous Injections, Intrathecal Injections, Subcutaneous Injections, Other Delivery Methods), and Regional Analysis, 2023-2030
... by Route of Administration (Intravenous Injections, Intrathecal Injections, Subcutaneous Injections, Other Delivery Methods), and Regional Analysis, 2023-2030 Global Antisense and RNAi therapeutics Market is valued approximately at USD 3.69 billion in 2022 and is anticipated ... Read More
-
Global RNA-interference (RNAi) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... 2.9 billion by 2029, growing at a CAGR of 16.29% during the forecast period (2024-2029). COVID-19 is expected to have a significant impact on the growth of the market. The demand for RNA interference is ... Read More
-
Global Antisense & RNAi Therapeutics Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... market growth of the Antisense & RNAi Therapeutics industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Antisense & RNAi Therapeutics. The report ... Read More
-
Antisense & RNAi Therapeutics Market Forecasts to 2030 – Global Analysis By Route of Administration (Subcutaneous Route, Intravenous Route, Pulmonary Delivery, Intrathecal Route, Intraperitoneal Injection and Other Routes of Administration), Indication (Autosomal Dominant Disease, Autosomal Recessive Disease, Chromosomal Disease and Other Indications), Technology, Application and By Geography
... Recessive Disease, Chromosomal Disease and Other Indications), Technology, Application and By Geography According to Stratistics MRC, the Global Antisense & RNAi Therapeutics Market is accounted for $1.66 billion in 2023 and is expected to reach ... Read More
-
Genome Editing Market by Technology (Antisense, CRISPR, Talen), Application (Cell Line Engineering, Genetic Engineering), End User - Global Forecast 2024-2030
... to reach USD 16.54 billion in 2024, at a CAGR 53.22% to reach USD 214.22 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Genome Editing Market. It offers ... Read More
-
Antisense & RNAi Therapeutics Market by Technology (Antisense RNA, RNA Interference), Application (Cardiovascular Diseases (CVDs), Genetic Disorders, Infectious Diseases), Route of Administration - Global Forecast 2024-2030
... at USD 4.51 billion in 2023 and expected to reach USD 4.93 billion in 2024, at a CAGR 9.34% to reach USD 8.43 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Gene Editing Technologies Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Antisense, CRISPR, Talen), Application, End User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 5.73 billion in 2024, at a CAGR 12.57% to reach USD 11.74 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Global Antisense & RNAi Therapeutics Market
... By Route of Administration (Intravenous Injections, Intrathecal Injections, Subcutaneous Injections and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) Antisense & RNAi therapeutics refer to a class of drugs ... Read More
-
RNAi Drug Delivery Market Report: Trends, Forecast and Competitive Analysis to 2030
... cardiology, oncology, neurology, ophthalmology, urology, and metabolic disorder markets. The global RNAi drug delivery market is expected to reach an estimated $3.5 billion by 2030 with a CAGR of 20.5% from 2024 to 2030. The ... Read More
-
Antisense & RNAi Therapeutics Market Size, Share & Trends Analysis Report By Technology (RNA Interference, Antisense RNA), By Application (Ocular Disorder, Genetic Disorder), By Route of Administration, By Region, And Segment Forecasts, 2024 - 2030
... Antisense & RNAi Therapeutics Market Growth & Trends The global antisense & RNAi therapeutics market size is expected to reach USD 14.66 billion by 2030, registering a CAGR of 18.12% from 2024 to 2030, according ... Read More
-
Global RNAi Biopesticides Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. RNAi biopesticides are a type of pest control technology that utilizes the natural biological process ... Read More
-
Global RNA Interference (RNAi)-Based Therapeutics Supply, Demand and Key Producers, 2023-2029
... CAGR during the forecast period (2023-2029). The Small Interfering RNA (siRNA) Drugs Market is driven by the transformative potential of siRNA-based therapies in silencing disease-associated genes, making them a promising approach for treating a wide ... Read More
-
Global RNAi Biopesticides Supply, Demand and Key Producers, 2023-2029
... (2023-2029). RNAi biopesticides are a type of pest control technology that utilizes the natural biological process of RNA interference to target and control specific pests. RNA interference is a mechanism that regulates gene expression by ... Read More
-
Global RNA Interference (RNAi)-Based Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... USD 1035.6 million in 2022 and is forecast to a readjusted size of USD 5308.7 million by 2029 with a CAGR of 26.3% during review period. The Small Interfering RNA (siRNA) Drugs Market is driven ... Read More
-
Global RNA Interference (RNAi)-Based Therapeutics Market Growth (Status and Outlook) 2023-2029
... With growing demand in downstream market, the RNA Interference (RNAi)-Based Therapeutics is forecast to a readjusted size of US$ 5698.4 million by 2029 with a CAGR of 28.5% during review period. The research report highlights ... Read More
-
Global RNAi Biopesticides Market Growth 2023-2029
... Biopesticides is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. The research report highlights the growth potential of the global RNAi Biopesticides market. RNAi Biopesticides ... Read More
-
RNAi Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030
... therapeutics market was valued at USD 11.20 billion in 2022 and is expected to reach USD 20.23 billion in 2030, with a CAGR of a 7.69% during the forecast period 2023-2030. The study on RNAi ... Read More
-
Antisense & RNAi Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type
... and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price is ... Read More
-
Gene Editing Market Forecasts to 2030 – Global Analysis By Product (Software & Systems, Services and Reagents & Consumables), Technology (Transcription Activator-Like Effector Nuclease, Antisense, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Zinc Finger Nuclease (ZFN) and Other Technologies), Application, End User and By Geography
... (ZFN) and Other Technologies), Application, End User and By Geography According to Stratistics MRC, the Global Gene Editing Market is accounted for $7.45 billion in 2023 and is expected to reach $23.05 billion by 2030 ... Read More
-
Antisense & RNAi Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.3% during 2023-2028. Antisense therapy is the selective and sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. It ... Read More
-
RNAi Technology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... period with a CAGR of 9.89% through 2028. The Global RNAi Technology Market is a dynamic and rapidly evolving sector within the biotechnology and pharmaceutical industries. RNA interference (RNAi) technology, a powerful tool for gene ... Read More
Research Assistance
